创新驱动"增长极"：模式革新与产业链协同，激活发展动能 在筑牢养殖根基的同时，新五丰积极探索创新路径，通过模式革新激发员工活力，依托产业链协同释放 发展势能，为企业高质量发展注入新动力。 创新推行的"模拟代养"模式，让员工从"打工者"转变为"经营者"。鼓励员工经营管理基地后，大家更主 动关注成本控制、生产效率与猪只健康，在实现个人收入提升的同时，也推动了企业效益增长，实现个 人与企业的双赢。 长沙晚报全媒体记者 曹开阳 周期性变化历来就是生猪产业必须破解的难题。2025年，湖南新五丰股份有限公司（以下简称"新五 丰"）及其旗下子公司迎难而上，从养殖端的精耕细作到模式上的创新突破，再到全链条的成本管控， 以一系列提质增效的"组合拳"，书写生猪产业发展的新篇章。 深耕养殖"基本盘"：双轮驱动，筑牢产业根基 母猪是生猪养殖的"核心芯片"，仔猪则是未来利润的"希望种子"。2025年以来，新五丰将提升母猪生产 效率与优化仔猪成本作为重中之重，通过科学管理与技术赋能，实现了养殖端的质效双升。 在母猪效率提升方面，新五丰多管齐下挖掘生产潜力：通过科学淘汰老龄低产母猪、引入健康高产后备 母猪，优化胎龄结构打造活力母猪群；广东 ...

Group 1 - The establishment of Jucheng Xincai (Beijing) Enterprise Management Partnership (Limited Partnership) with a registered capital of 2.375 billion yuan [1] - The business scope includes enterprise management and enterprise management consulting [1] - The company is jointly held indirectly by China Chengtong Holdings Group Co., Ltd. and China National Building Material Group Corporation [1]

"死磕降本是生猪养殖企业的当务之急。"这已成为2025年生猪养殖企业的生存共识。 新五丰是国内较早的生猪规模化养殖实践者，一直将生猪养殖作为公司重点发展的核心业务。近年 来，公司以生猪养殖为基础，通过机制创新，提质增效，降低成本，正在探索生猪养殖高质量发展之 路。 降低成本，提升生猪生产成本竞争力 面对猪价跌跌不休、产能去化远水难解近渴，猪企的当务之急还是死磕降本。 "今年3月开始，随着玉米价格的上涨，我们饲料用料由玉米切换到小麦，每吨饲料节约了50元左 右，通过饲料配方的切换，饲料成本优化空间达到了5%，上半年光饲料成本节约了2700万元。"新五丰 分管饲料板块的周庆华副总经理说。 目前，新五丰的饲料板块的技术团队，从营养技术提高、本地资源替代蛋白饲料、分阶段精细管理 营养等多方面降低饲料成本，不断提升公司行业竞争力。 衡南晟峰母猪场是新五峰的母猪标杆场，位于衡南县花桥镇，母猪设计规模1.2万头。衡南晟峰的 场长赵菊文说，控制成本是我们猪场的重要工作之一，精准控制喂料成本、强化内部考核遏制浪费行 为、培养饲养人员责任心等多方面都在降低成本。 "针对这个生长阶段仔猪的营养需求，要采用少食多餐的方式喂养，减少饲 ...

Group 1 - The establishment of Nengcheng Juliyi (Tianjin) Enterprise Management Partnership (Limited Partnership) with a registered capital of 3.125 billion yuan [1] - The business scope includes enterprise management and enterprise management consulting [1] - The company is jointly funded by Beijing Chengtong Capital Investment Co., Ltd., a wholly-owned subsidiary of China Chengtong Holdings Group Co., Ltd., and China Energy Engineering Group Co., Ltd. along with its subsidiary, China Energy Construction Fund Management Co., Ltd. [1]

从资金流向上来看，当日养殖业板块主力资金净流入1124.65万元，游资资金净流入248.51万元，散户资 金净流出1373.16万元。养殖业板块个股资金流向见下表： | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 000735 | 罗牛山 | 4270.10万 | 1.53% | -2381.34万 | -0.85% | -1888.76万 | -0.68% | | 300498 温氏股份 | | 2160.29万 | 5.09% | -1022.58万 | -2.41% | -1137.71万 | -2.68% | | 300967 晓鸣股份 | | 728.00万 | 7.51% | 107.64万 | 1.11% | -835.64万 | -8.62% | | 605296 神农集团 | | 643.70万 | 9.91% | -132.66万 | -2.04% | -511.04万 | -7.86% | | ...

证券代码：600975 证券简称：新五丰 公告编号：2025-061 湖南新五丰股份有限公司 2025年11月生猪业务主要经营数据公告 登录新浪财经APP 搜索【信披】查看更多考评等级 二、特别说明与风险提示 1、上述数据均未经审计，与定期报告披露的数据之间可能存在差异，上述数据仅作为阶段性数据，供 投资者参考。因四舍五入，以上数据可能存在尾差。 2、基于动物疫情对生猪行业的影响持续存在、生猪市场价格波动较大以及公司养殖节奏变化等因素影 响，未来公司生猪销量存在月度波动风险。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 湖南新五丰股份有限公司（以下简称"公司"或"本公司"）现将2025年11月主要经营数据公告如下： 一、主要经营数据 （一）生猪销售情况 1、2025年11月公司生猪销售情况 ■ 2、2025年11月，公司销售生猪数量57.55万头，其中：销售商品猪33.83万头。 ■■ 3、生猪市场价格变动的风险是整个生猪生产行业的系统风险，对任何一家生猪生产者来讲都是客观存 在的、不可控制的外部风险。 三、其他提示 本公 ...

Group 1 - Wanma Technology has been pre-awarded a total of 59.9434 million yuan for multiple State Grid projects, which accounts for 14.49% of its latest audited main business revenue [1] - Tianen Kang's subsidiary received a drug registration certificate for Methimazole tablets, a medication used for hyperthyroidism [2] - Taijing Technology invested 10 million yuan to establish a special fund focused on high-speed network communication chips [3] Group 2 - Youyou Foods plans to use 10 million yuan of its own funds to purchase principal-protected financial products with an expected annual yield of 0.5%-5.0% [4] - Yangfan New Materials announced the release of detention measures against its controlling shareholder, allowing him to resume his duties [5] - Xianju Pharmaceutical received approval for a supplementary application for Nicardipine injection, a calcium channel blocker used for acute hypertension [6] Group 3 - Jingu Co. plans to repurchase shares worth 30-60 million yuan for employee stock ownership plans or equity incentives [7] - Double Tower Foods' Thai subsidiary has completed the construction of its production line and is in the initial production phase [8] - Tongyi Zhong intends to invest approximately 198 million yuan in a project for the industrialization of ultra-high molecular weight polyethylene fibers [9][10] Group 4 - Zhangyue Technology received a dividend of 4.99 million yuan from its stake in Dianzhong Technology, which represents 10.12% of its audited net profit for 2024 [11] - Sihua Electronics announced the resignation of its general manager due to job transfer, with the current manager continuing until a new one is appointed [12] - Jiutian Pharmaceutical's new drug JMHT06 has received approval for clinical trials for acute gouty arthritis [13] Group 5 - Anlian Ruishi has established a joint venture for embodied intelligent robots with a registered capital of 20 million yuan [14] - Kelin Electric's application for a private placement has been accepted by the Shanghai Stock Exchange [15] - Guoyao Modern's subsidiary has received approval for the listing of Agomelatine raw materials, used in antidepressant synthesis [16] Group 6 - Xintiandi's application for the listing of Ferrous Fumarate raw materials has been approved, which is used for treating iron deficiency anemia [17] - ST Weihai, as the leading party, won a bid for a smart agriculture project worth 652 million yuan, accounting for 26.27% of its 2024 audited revenue [18] - Tian Youwei plans to purchase 100% of Krämer Automotive Systems for 1 million euros [19] Group 7 - Guangdong Yuedian A's subsidiary has successfully put into operation the third unit of its Dapu Power Plant project [20] - China Life's total premium exceeded 700 billion yuan as of November 30, 2025 [21] - Shoukai Co. achieved a total signed amount of 15.988 billion yuan in the first 11 months of 2025 [22] Group 8 - Kehua Bio's subsidiary has obtained a medical device registration certificate for an automatic chemiluminescence immunoassay analyzer [23] - Chengyi Pharmaceutical received a drug registration certificate for Torasemide tablets, which have passed the consistency evaluation [24] - Chongqing Construction won a bid for a municipal engineering project worth approximately 1.714 billion yuan [25] Group 9 - Hanjian Heshan signed a procurement contract for pipes worth 388 million yuan [26] - Jiuzhou Pharmaceutical plans to use up to 1 billion yuan of idle raised funds for cash management [27] - Xinwufeng reported an 80.97% year-on-year increase in pig sales in November 2025 [28] Group 10 - Luoniushan reported a 13.57% year-on-year increase in pig sales revenue in November 2025 [29] - Fushilai received a drug registration certificate for Alpha-Lipoic Acid tablets, used for diabetic neuropathy [30] - Dizhe Pharmaceutical presented research data on two innovative drugs at the 67th American Society of Hematology conference [31] - David Medical's subsidiary received two medical device registration certificates for single-use gastric tubes and electronic ureteral endoscope catheters [32]

证券代码：600975 证券简称：新五丰 公告编号：2025-061 湖南新五丰股份有限公司 2025 年 11 月生猪业务主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 湖南新五丰股份有限公司（以下简称"公司"或"本公司"）现将 2025 年 11 月主要经营数据公告如下： 2、2025 年 11 月，公司销售生猪数量 57.55 万头，其中：销售商品猪 33.83 万头。 | 月份 | 生猪销量（万头） | | 商品猪销量 | | 商品猪 | | --- | --- | --- | --- | --- | --- | | | | | （万头） | | 销价 | | | 当月 | 累计 | 当月 | 累计 | （元/公斤） | | 4 月 | 40.81 | 167.48 | 24.08 | 93.90 | 14.82 | | 5 月 | 38.70 | 206.18 | 24.35 | 118.25 | 14.72 | | 6 月 | 37.15 | 243.33 | 21.92 | 140.17 | 1 ...

智通财经APP讯，新五丰(600975.SH)公告，公司2025年11月销售生猪数量57.55万头，其中：销售商品 猪33.83万头。 ...

格隆汇12月9日丨新五丰(600975.SH)公布，2025年11月，公司销售生猪数量57.55万头，其中：销售商品 猪33.83万头。 ...